Annual CFO
$22.74 M
+$107.21 M+126.93%
31 December 2023
Summary:
Assembly Biosciences annual cash flow from operations is currently $22.74 million, with the most recent change of +$107.21 million (+126.93%) on 31 December 2023. During the last 3 years, it has risen by +$85.70 million (+136.12%). ASMB annual CFO is now at all-time high.ASMB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$15.24 M
+$1.86 M+10.86%
30 September 2024
Summary:
Assembly Biosciences quarterly cash flow from operations is currently -$15.24 million, with the most recent change of +$1.86 million (+10.86%) on 30 September 2024. Over the past year, it has dropped by -$1.40 million (-10.08%). ASMB quarterly CFO is now -120.70% below its all-time high of $73.65 million, reached on 31 December 2023.ASMB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$22.94 M
-$1.40 M-5.74%
30 September 2024
Summary:
Assembly Biosciences TTM cash flow from operations is currently $22.94 million, with the most recent change of -$1.40 million (-5.74%) on 30 September 2024. Over the past year, it has increased by +$93.09 million (+132.69%). ASMB TTM CFO is now -17.51% below its all-time high of $27.81 million, reached on 31 March 2024.ASMB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +126.9% | -10.1% | +132.7% |
| 3 y3 years | +136.1% | +19.3% | +123.1% |
| 5 y5 years | +135.0% | +18.0% | +128.6% |
ASMB Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +124.3% | -120.7% | +44.6% | -17.5% | +123.1% |
| 5 y | 5 years | at high | +124.3% | -120.7% | +54.3% | -17.5% | +123.1% |
| alltime | all time | at high | +124.3% | -120.7% | +54.3% | -17.5% | +123.1% |
Assembly Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$15.24 M(-10.9%) | $22.94 M(-5.7%) |
| June 2024 | - | -$17.10 M(-6.9%) | $24.33 M(-12.5%) |
| Mar 2024 | - | -$18.36 M(-124.9%) | $27.81 M(+22.3%) |
| Dec 2023 | $22.74 M(-126.9%) | $73.65 M(-631.8%) | $22.74 M(-132.4%) |
| Sept 2023 | - | -$13.85 M(+1.6%) | -$70.16 M(-7.8%) |
| June 2023 | - | -$13.63 M(-41.8%) | -$76.13 M(-5.3%) |
| Mar 2023 | - | -$23.43 M(+21.7%) | -$80.39 M(-4.8%) |
| Dec 2022 | -$84.46 M(-9.6%) | -$19.25 M(-2.9%) | -$84.46 M(-0.1%) |
| Sept 2022 | - | -$19.82 M(+10.8%) | -$84.57 M(+1.1%) |
| June 2022 | - | -$17.89 M(-35.0%) | -$83.63 M(-4.5%) |
| Mar 2022 | - | -$27.50 M(+42.0%) | -$87.55 M(-6.3%) |
| Dec 2021 | -$93.40 M(+48.3%) | -$19.36 M(+2.5%) | -$93.40 M(-5.9%) |
| Sept 2021 | - | -$18.88 M(-13.4%) | -$99.30 M(+42.3%) |
| June 2021 | - | -$21.81 M(-34.6%) | -$69.78 M(-1.8%) |
| Mar 2021 | - | -$33.34 M(+32.0%) | -$71.08 M(+12.9%) |
| Dec 2020 | -$62.96 M(-25.1%) | -$25.27 M(-337.4%) | -$62.96 M(+8.1%) |
| Sept 2020 | - | $10.65 M(-146.1%) | -$58.22 M(-33.4%) |
| June 2020 | - | -$23.12 M(-8.3%) | -$87.46 M(+2.5%) |
| Mar 2020 | - | -$25.22 M(+22.8%) | -$85.35 M(+1.5%) |
| Dec 2019 | -$84.07 M(+29.4%) | -$20.53 M(+10.4%) | -$84.07 M(+4.7%) |
| Sept 2019 | - | -$18.59 M(-11.5%) | -$80.27 M(+2.4%) |
| June 2019 | - | -$21.00 M(-12.3%) | -$78.36 M(+6.8%) |
| Mar 2019 | - | -$23.94 M(+43.1%) | -$73.40 M(+13.0%) |
| Dec 2018 | -$64.96 M(-3592.4%) | -$16.73 M(+0.3%) | -$64.96 M(+12.0%) |
| Sept 2018 | - | -$16.68 M(+4.0%) | -$58.00 M(+11.0%) |
| June 2018 | - | -$16.05 M(+3.5%) | -$52.27 M(+7.6%) |
| Mar 2018 | - | -$15.50 M(+58.6%) | -$48.58 M(-2712.1%) |
| Dec 2017 | $1.86 M(-105.3%) | -$9.77 M(-10.8%) | $1.86 M(+215.0%) |
| Sept 2017 | - | -$10.96 M(-11.3%) | $590.50 K(-84.0%) |
| June 2017 | - | -$12.36 M(-135.4%) | $3.68 M(-60.3%) |
| Mar 2017 | - | $34.94 M(-416.5%) | $9.27 M(-126.6%) |
| Dec 2016 | -$34.88 M | -$11.04 M(+40.4%) | -$34.88 M(+19.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | -$7.86 M(+16.2%) | -$29.30 M(+10.1%) |
| June 2016 | - | -$6.77 M(-26.5%) | -$26.62 M(+9.8%) |
| Mar 2016 | - | -$9.21 M(+68.8%) | -$24.23 M(+29.6%) |
| Dec 2015 | -$18.70 M(+24.9%) | -$5.46 M(+5.2%) | -$18.70 M(+11.1%) |
| Sept 2015 | - | -$5.19 M(+18.3%) | -$16.84 M(+8.4%) |
| June 2015 | - | -$4.38 M(+19.3%) | -$15.52 M(+15.3%) |
| Mar 2015 | - | -$3.67 M(+2.2%) | -$13.46 M(-10.1%) |
| Dec 2014 | -$14.97 M(-15.9%) | -$3.59 M(-7.3%) | -$14.97 M(-10.7%) |
| Sept 2014 | - | -$3.88 M(+67.0%) | -$16.77 M(-4.4%) |
| June 2014 | - | -$2.32 M(-55.2%) | -$17.55 M(-5.7%) |
| Mar 2014 | - | -$5.19 M(-3.8%) | -$18.61 M(+4.6%) |
| Dec 2013 | -$17.80 M(-16.8%) | -$5.39 M(+15.8%) | -$17.80 M(+15.0%) |
| Sept 2013 | - | -$4.66 M(+37.8%) | -$15.47 M(-3.9%) |
| June 2013 | - | -$3.38 M(-22.7%) | -$16.10 M(-18.1%) |
| Mar 2013 | - | -$4.37 M(+42.3%) | -$19.66 M(-8.0%) |
| Dec 2012 | -$21.38 M(-14.7%) | -$3.07 M(-41.9%) | -$21.38 M(-38.3%) |
| Sept 2012 | - | -$5.28 M(-23.8%) | -$34.64 M(+3.6%) |
| June 2012 | - | -$6.94 M(+13.9%) | -$33.43 M(+13.9%) |
| Mar 2012 | - | -$6.09 M(-62.7%) | -$29.34 M(+17.1%) |
| Dec 2011 | -$25.07 M(+380.8%) | -$16.33 M(+301.4%) | -$25.07 M(+151.8%) |
| Sept 2011 | - | -$4.07 M(+42.7%) | -$9.95 M(+44.1%) |
| June 2011 | - | -$2.85 M(+57.1%) | -$6.91 M(+31.8%) |
| Mar 2011 | - | -$1.81 M(+49.0%) | -$5.24 M(+0.5%) |
| Dec 2010 | -$5.21 M(+49.7%) | -$1.22 M(+19.3%) | -$5.21 M(-0.1%) |
| Sept 2010 | - | -$1.02 M(-13.7%) | -$5.22 M(+10.9%) |
| June 2010 | - | -$1.18 M(-33.9%) | -$4.71 M(+19.3%) |
| Mar 2010 | - | -$1.79 M(+46.3%) | -$3.94 M(+13.2%) |
| Dec 2009 | -$3.48 M(-16.0%) | -$1.22 M(+141.3%) | -$3.48 M(+54.2%) |
| Sept 2009 | - | -$507.20 K(+20.3%) | -$2.26 M(+28.9%) |
| June 2009 | - | -$421.60 K(-68.3%) | -$1.75 M(+31.7%) |
| Mar 2009 | - | -$1.33 M | -$1.33 M |
| Dec 2008 | -$4.15 M | - | - |
FAQ
- What is Assembly Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Assembly Biosciences?
- What is Assembly Biosciences annual CFO year-on-year change?
- What is Assembly Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Assembly Biosciences?
- What is Assembly Biosciences quarterly CFO year-on-year change?
- What is Assembly Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Assembly Biosciences?
- What is Assembly Biosciences TTM CFO year-on-year change?
What is Assembly Biosciences annual cash flow from operations?
The current annual CFO of ASMB is $22.74 M
What is the all time high annual CFO for Assembly Biosciences?
Assembly Biosciences all-time high annual cash flow from operations is $22.74 M
What is Assembly Biosciences annual CFO year-on-year change?
Over the past year, ASMB annual cash flow from operations has changed by +$107.21 M (+126.93%)
What is Assembly Biosciences quarterly cash flow from operations?
The current quarterly CFO of ASMB is -$15.24 M
What is the all time high quarterly CFO for Assembly Biosciences?
Assembly Biosciences all-time high quarterly cash flow from operations is $73.65 M
What is Assembly Biosciences quarterly CFO year-on-year change?
Over the past year, ASMB quarterly cash flow from operations has changed by -$1.40 M (-10.08%)
What is Assembly Biosciences TTM cash flow from operations?
The current TTM CFO of ASMB is $22.94 M
What is the all time high TTM CFO for Assembly Biosciences?
Assembly Biosciences all-time high TTM cash flow from operations is $27.81 M
What is Assembly Biosciences TTM CFO year-on-year change?
Over the past year, ASMB TTM cash flow from operations has changed by +$93.09 M (+132.69%)